Challenges Faced by Male Contraceptives

For decades, the development of male contraceptives has lagged behind women's contraceptive options. This is partly due to social norms that associate reproductive responsibility with women. Funding for women's reproductive health has been prioritized, while research challenging traditional gender roles has been hindered. Furthermore, pharmaceutical companies have shown less interest in funding male contraceptives, citing concerns about profitability. However, progress is being made in the field of non-hormonal male contraceptives, with promising methods being explored, such as drugs that affect sperm movement or block access to vitamin A.